Vicks Flu Therapy
NDC Package 37000-539-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vicks Flu Therapy is a . Marketed by The Procter & Gamble Manufacturing Company, this product is identified by NDC 37000-539 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
37000-539-01
Package Description
6 POUCH in 1 BLISTER PACK / 5 g in 1 POUCH
Product Code
37000-539
11-Digit Billing Format
37000053901

Clinical Specifications

Proprietary Name
Vicks Flu Therapy Severe Cold And Flu Day
Dosage Form
-

Regulatory & Marketing

Labeler Name
The Procter & Gamble Manufacturing Company
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-17-2019
End Marketing Date
04-17-2019
Listing Expiration
04-17-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 37000-539-01 identifies a specific commercial package of 6 pouch in 1 blister pack / 5 g in 1 pouch of Vicks Flu Therapy Severe Cold And Flu Day, labeled by The Procter & Gamble Manufacturing Company. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by The Procter & Gamble Manufacturing Company on April 17, 2019. The current certification is valid through April 17, 2019.

How is this The Procter & Gamble Manufacturing Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 37000053901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
37000-539-01
11-Digit CMS (5-4-2)
37000-0539-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.